Company ViaDerma, Inc. Other OTC
Equities
VDRM
US92555K1016
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Topical Antibiotic
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +11.07% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +11.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 14-03-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 14-03-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,228,143,498 | 1,215,862,063 ( 99.00 %) | 0 | 99.00 % |
Company contact information
ViaDerma, Inc.
4640 Admiralty Way Suite 500
90292, Marina Del Rey
+
Sector
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |